Management of vaccinations in patients with non-Hodgkin lymphoma

被引：1

作者：

Merli, Michele ^{[1
]}

Costantini, Andrea ^{[2
]}

Tafuri, Silvio ^{[3
]}

Bavaro, Davide Fiore ^{[4
]}

Minoia, Carla ^{[5
]}

Meli, Erika ^{[6
]}

Luminari, Stefano ^{[7
,8
,10
]}

Gini, Guido ^{[9
]}

机构：

[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Hematol, Milan, Italy

[2] Univ Politecn Marche, Azienda Ospedaliero Univ Marche, Clin Immunol Unit, Ancona, Italy

[3] Aldo Moro Univ Bari, Dept Biomed Sci & Human Oncol, Bari, Italy

[4] Aldo Moro Univ Bari, Dept Biomed Sci & Human Oncol, Clin Infect Dis, Bari, Italy

[5] IRCCS Ist Tumori Giovanni Paolo II, Hematol Unit, Bari, Italy

[6] ASST Grande Osped Metropolitano Niguarda, Div Hematol, Milan, Italy

[7] Azienda USL IRCCS Reggio Emilia, Hematol Unit, Reggio Emilia, Italy

[8] Univ Modena & Reggio Emilia, Surg Med & Dent Dept Morphol Sci Related Transplan, Modena, Italy

[9] Univ Politecn Marche, Azienda Ospedaliero Univ Marche, Clin Hematol, Ancona, Italy

[10] Univ Modena & Reggio Emilia, CHIMOMO Dept, Hematol Unit, Azienda USL IRCCS Reggio Emilia, Viale Risorgimento 80, I-42123 Reggio Emilia, Italy

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2024年 / 204卷 / 05期

关键词：

COVID-19; non-Hodgkin lymphomas; rituximab; vaccines; zoster; PNEUMOCOCCAL CONJUGATE VACCINE; RESPIRATORY SYNCYTIAL VIRUS; PRACTICES-UNITED STATES; MESSENGER-RNA VACCINE; HEPATITIS-B-VIRUS; ADVISORY-COMMITTEE; INFLUENZA VACCINE; HEMATOLOGICAL MALIGNANCIES; COVID-19; VACCINATION; CELL TRANSPLANTATION;

D O I：

10.1111/bjh.19422

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Vaccinations are fundamental tools in preventing infectious diseases, especially in immunocompromised patients like those affected by non-Hodgkin lymphomas (NHLs). The COVID-19 pandemic made clinicians increasingly aware of the importance of vaccinations in preventing potential life-threatening SARS-CoV-2-related complications in NHL patients. However, several studies have confirmed a significant reduction in vaccine-induced immune responses after anti-CD20 monoclonal antibody treatment, thus underscoring the need for refined immunization strategies in NHL patients. In this review, we summarize the existing data about COVID-19 and other vaccine's efficacy in patients with NHL and propose multidisciplinary team-based recommendations for the management of vaccines in this specific group of patients.

引用

下载

页码：1617 / 1634

页数：18

共 50 条

[1] CONTROVERSIES IN THE MANAGEMENT OF NON-HODGKIN LYMPHOMA
ENGERT, A
DIEHL, V
EUROPEAN JOURNAL OF CANCER, 1991, 27 (03) : 309 - 315
[2] Invasive aspergillosis in patients with hodgkin and non-hodgkin lymphoma
Chudinovskikh, Julia
Semiglazova, Tatiana
Shadrivova, Olga
Frolova, Ekaterina
Bogomolova, Tatiana
Ignatyeva, Svetlana
Alekseev, S.
Zuzgin, Ilya
Harchenko, Evgeniya
Oleinik, Julia
Smirnova, Anastasia
Klimko, Nikolai
MEDICAL MYCOLOGY, 2018, 56 : S97 - S97
[3] Proton therapy in the management of non-Hodgkin lymphoma
Sachsman, Suzanne
Flampouri, Stella
Li, Zuofeng
Lynch, James
Mendenhall, Nancy P.
Hoppe, Bradford S.
LEUKEMIA & LYMPHOMA, 2015, 56 (09) : 2608 - 2612
[4] Medical management update: Non-Hodgkin lymphoma
Mawardi, Hani
Cutler, Corey
Treister, Nathaniel
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2009, 107 (01): : E19 - E33
[5] Modern management of non-Hodgkin lymphoma in HIV-infected patients
Mounier, Nicolas
Spina, Michele
Gisselbrecht, Christian
BRITISH JOURNAL OF HAEMATOLOGY, 2007, 136 (05) : 685 - 698
[6] Non-Hodgkin lymphoma
Armitage, James O.
Gascoyne, Randy D.
Lunning, Matthew A.
Cavalli, Franco
LANCET, 2017, 390 (10091): : 298 - 310
[7] Non-Hodgkin lymphoma
Shankland, Kate R.
Armitage, James O.
Hancock, Barry W.
LANCET, 2012, 380 (9844): : 848 - 857
[8] Non-Hodgkin lymphoma
Evans, LS
Hancock, BW
LANCET, 2003, 362 (9378): : 139 - 146
[9] The Experience of Illness in Non-Hodgkin Lymphoma Patients
Kim, Hye Sook
Yi, Myungsun
ASIAN ONCOLOGY NURSING, 2016, 16 (03) : 121 - 131
[10] Splenectomy in patients with non-Hodgkin's lymphoma
Xiros, N
Economopoulos, T
Christodoulidis, C
Dervenoulas, J
Papageorgiou, E
Mellou, S
Tsirigotis, P
Bolas, G
Raptis, S
EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1208 - 1208

← 1 2 3 4 5 →